Skip to main content
Clinical Trials/IRCT20230116057135N3
IRCT20230116057135N3RecruitingPhase 3

Investigating the effect of the Nutrition Bio-Shield (NBS) herbal supplement on the treatment of patients with nosocomial multi-drug resistant bloodstream infections admitted to emergency Intensive care unit.

Tehran University of Medical Sciences0 sites94 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
94

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Confirmation of the occurrence of sepsis in patients with the initial assessment of the patient's clinical symptoms and laboratory parameters
  • Patients over 18 years old
  • Primary diagnosis of sepsis (have at least two of the following four symptoms: hypothermia or hyperthermia, tachycardia, tachypnea, and leukocytosis or leukopenia) by an infectious specialist or a positive MDR culture

Exclusion Criteria

  • History of consuming corticosteroids and immunosuppressive drugs
  • Pregnant and lactating mothers

Investigators

Similar Trials